Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Tubacex SA
MAD:TUB
|
ES |
|
GDH Guangnan (Holdings) Ltd
OTC:GUGNF
|
HK |
|
Bank of Ningbo Co Ltd
SZSE:002142
|
CN |
|
J B Hunt Transport Services Inc
NASDAQ:JBHT
|
US |
|
J
|
J B Hunt Transport Services Inc
XBER:JB1
|
US |
|
G
|
Grifols SA
MAD:GRF.P
|
ES |
|
I
|
Integra Lifesciences Holdings Corp
XMUN:IL3
|
US |
|
Amcor PLC
F:485B
|
UK |
|
Obic Business Consultants Co Ltd
TSE:4733
|
JP |
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
US |
Dividends
Dividend Yield
Centessa Pharmaceuticals PLC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Centessa Pharmaceuticals PLC
CNTA have decreased by 0%.
Payout Ratio
Centessa Pharmaceuticals PLC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CNTA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CNTA Price
Centessa Pharmaceuticals PLC
| Average Annual Return | 39.14% |
| Standard Deviation of Annual Returns | 114.94% |
| Max Drawdown | -87% |
| Market Capitalization | 6.3B USD |
| Shares Outstanding | 154 730 000 |
| Percentage of Shares Shorted | 1.22% |
